Clinical Trial Update: Efficacy of Pyrotinib Plus Capecitabine in HER2-positive MBC With Active Brain Metastases That Have Failed ADCs [Phase 2]

View source ↗

Summary

A Phase 2 trial evaluating Pyrotinib plus Capecitabine for HER2-positive metastatic breast cancer with active brain metastases that have progressed after ADC th…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer
• Breast Cancer with Brain Metastases

Drugs mentioned

• Capecitabine (capecitabine)
• Pyrotinib (pyrotinib)

Snippet

Sponsor: Henan Cancer Hospital | Conditions: Metastatic Breast Cancer in the Brain | Phase 2 | Status: NOT_YET_RECRUITING